Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease

Background/Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become an increasingly important health challenge, with a substantial rise linked to changing lifestyles and global obesity. Ursolic acid, a natural pentacyclic triterpenoid, has been explored for its potential the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and molecular hepatology 2024-07, Vol.30 (3), p.449
Hauptverfasser:	Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li
Format:	Artikel
Sprache:	kor
Schlagworte:	Metabolic dysfunction-associated steatotic liver disease Secreted phosphoprotein 1 Th17 cells Ursolic acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!